Last Updated: November 16, 2026

Investigational Drug Information for SAGE-718

« Back to Dashboard


What is the development status for investigational drug SAGE-718?

SAGE-718 is an investigational drug.

There have been 11 clinical trials for SAGE-718. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2022.

The most common disease conditions in clinical trials are Cognitive Dysfunction, Huntington Disease, and Alzheimer Disease. The leading clinical trial sponsors are Sage Therapeutics and [disabled in preview].

There are five US patents protecting this investigational drug and fifty international patents.

Recent Clinical Trials for SAGE-718
TitleSponsorPhase
A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)Sage TherapeuticsPhase 2
A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's DiseaseSage TherapeuticsPhase 3
A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive ImpairmentSage TherapeuticsPhase 2

See all SAGE-718 clinical trials

Clinical Trial Summary for SAGE-718

Top disease conditions for SAGE-718
Top clinical trial sponsors for SAGE-718

See all SAGE-718 clinical trials

US Patents for SAGE-718

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
SAGE-718 ⤷  Start Trial Neuroactive steroids and methods of use thereof Sage Therapeutics LLC ⤷  Start Trial
SAGE-718 ⤷  Start Trial Oxysterols and methods of use thereof Sage Therapeutics LLC ⤷  Start Trial
SAGE-718 ⤷  Start Trial Neuroactive steroids and methods of use thereof Sage Therapeutics LLC ⤷  Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.